References
- AlAli A, Kletke S, Gallie B, et al. Retinoblastoma for pediatric ophthalmologists. Asia Pac J Ophthalmol (Phila). 2018;7(3):160–168.
- Tian-Geng H, Xiao Z-Y, Xing Y-Q, et al. Tumor suppressor miR-184 enhances chemosensitivity by directly inhibiting SLC7A5 in retinoblastoma. Front Oncol. 2019 Nov 15;9:1163.
- Chen J, Rodriguez C, Monestel R, et al. Clinical, epidemiological, and therapeutic profile of patients with a retinoblastoma diagnosis experience in the Costa Rica Ntional Children’s Hospital oncology unit from january 2009 to december 2015. Ecancer. 2017;11(7):1–9.
- Friedman DL, Himelstein B, Shields CL, et al. Chemoreduction and local ophthalmic therapy for intraocular retinoblastoma. J Clin Oncol. 2000;18(1):12–17.
- Bu W, Wang Y, Min X. MicroRNA-106b promotes the proliferation, migration and invasion of retinoblastoma cells by inhibiting the expression of ZBTB4 protein. Exp Ther Med. 2018 Dec;16(6):4537–4545.
- Yang M, Wei W. Long non-coding RNAs in retinoblastoma. Pathol Res Pract. 2019 Aug;215(8):152435.
- Yang Z, Jiang X, Jiang X, et al. X-inactive-specific transcript: a long noncoding RNA with complex roles in human cancers. Gene. 2018 Dec;679(679):28–35.
- Hu C, Liu S, Han M, et al. Knockdown of lncRNA XIST inhibits retinoblastoma progression by modulating the miR-124/STAT3 axis. Biomed Pharmacother. 2018 Nov;107:547–554.
- Cheng Y, Chang Q, Zheng B, et al. LncRNA XIST promotes the epithelial to mesenchymal transition of retinoblastoma via sponging miR-101. Eur J Pharmacol. 2019 Jan 15;843:210–216.
- Cai Y, Yu X, Hu S, et al. A brief review on the mechanisms of miRNA regulation. Genomics Proteomics Bioinformatics. 2009 Dec;7(4):147–154.
- Liu S, Hu C, Wang Y, et al. MiR-124 inhibits proliferation and invasion of human retinoblastoma cells by targeting STAT3. Oncol Rep. 2016 Oct;36(4):2398–2404.
- Zhao Y, Zhang S, Zhang Y. MicroRNA-320 inhibits cell proliferation, migration and invasion in retinoblastoma by targeting specificity protein 1. Mol Med Rep. 2017 Aug;16(2):2191–2198.
- Chen B, Zheng ZY, Yang JZ, et al. MicroRNA-191-5p promotes the development of osteosarcoma via targeting EGR1 and activating the PI3K/AKT signaling pathway. Eur Rev Med Pharmacol Sci. 2019 May;23(9):3611–3620.
- Chen P, Pan X, Zhao L, et al. MicroRNA-191-5p exerts a tumor suppressive role in renal cell carcinoma. Exp Ther Med. 2018 Feb;15(2):1686–1693.
- McAllister AK. Neurotrophins and neuronal differentiation in the central nervous system. Cell Mol Life Sci. 2001;58(8):1054–1060.
- Song D, Diao J, Yang Y, et al. MicroRNA-382 inhibits cell proliferation and invasion of retinoblastoma by targeting BDNF-mediated PI3K/AKT signalling pathway. Mol Med Rep. 2017 Nov;16(5):6428–6436.
- Colucci-D’Amato L, Speranza L, Volpicelli F. Neurotrophic factor BDNF, physiological functions and therapeutic potential in depression, neurodegeneration and brain cancer. Int J Mol Sci. 2020 Oct 21;21(20):7777.
- Song H, He P, Shao T, et al. Long non-coding RNA XIST functions as an oncogene in human colorectal cancer by targeting miR-132-3p. J Buon. 2017 May-Jun;22(3):696–703.
- Wei W, Liu Y, Lu Y, et al. LncRNA XIST Promotes Pancreatic Cancer Proliferation Through miR-133a/EGFR. J Cell Biochem. 2017 Oct;118(10):3349–3358.
- Chen L, Zhou Y, Li H. LncRNA, miRNA and lncRNA-miRNA interaction in viral infection. Virus Res. 2018 Sep;15(257):25–32.
- Huang SM, Lin C, Lin HY, et al. Brain-derived neurotrophic factor regulates cell motility in human colon cancer. Endocr Relat Cancer. 2015;22(3):455–464.
- Tsai YF, Tseng LM, Hsu CY, et al. Brain-derived neurotrophic factor (BDNF) -TrKB signaling modulates cancer-endothelial cells interaction and affects the outcomes of triple negative breast cancer. PLoS One. 2017 Jun 12;12(6):e0178173.